Tibet AIM Pharm. Inc. (SHE:002826)

Tibet AIM Pharm. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Operating Revenue	670.21	636.17	649.72	666.8	856.53	724.36
Other Revenue	0.11	0.11	2.16	0.23	0.21	1.1
Revenue	670.32	636.27	651.88	667.04	856.73	725.46
Revenue Growth (YoY)	4.74%	-2.40%	-2.27%	-22.14%	18.09%	20.38%
Cost of Revenue	115.91	113.82	205.54	325.59	480.7	464.96
Gross Profit	554.41	522.45	446.34	341.45	376.03	260.5
Selling, General & Admin	452.39	433.58	390.65	298.35	317.92	218.48
Research & Development	14.07	14.67	15.48	13.71	13.35	11.39
Other Operating Expenses	20.91	10.83	12.27	11.5	-8.2	-9.81
Operating Expenses	486.68	457.84	419.08	316.54	329.71	218.93
Operating Income	67.73	64.62	27.26	24.91	46.32	41.58
Interest Expense	-0.83	-1	-0.45	-1.18	-0.81	-0.84
Interest & Investment Income	4.02	3.94	5.2	5.06	3.93	2.92
Currency Exchange Gain (Loss)	-0	-0	0	0	0	-0
Other Non Operating Income (Expenses)	1.18	0.79	-0.3	1.06	3.23	2.8
EBT Excluding Unusual Items	72.1	68.35	31.71	29.85	52.68	46.46
Impairment of Goodwill	-	-	-	-19.8	-	-
Gain (Loss) on Sale of Assets	-0.09	-0.23	-0.04	0.03	-	0.03
Asset Writedown	-2.75	-2.75	-0.2	-0.13	-0.08	-0.08
Other Unusual Items	48.31	48.31	28.91	13.65	4.1	3.6
Pretax Income	117.57	113.67	60.38	23.6	56.7	50.01
Income Tax Expense	23.73	20.55	12.92	7.87	10.59	6.54
Earnings From Continuing Operations	93.84	93.12	47.46	15.73	46.12	43.47
Minority Interest in Earnings	-0.41	-0.54	-1.53	-0.34	-1.98	-1
Net Income	93.44	92.58	45.93	15.39	44.14	42.48
Net Income to Common	93.44	92.58	45.93	15.39	44.14	42.48
Net Income Growth	153.74%	101.57%	198.50%	-65.14%	3.91%	3.37%
Shares Outstanding (Basic)	179	185	184	192	192	193
Shares Outstanding (Diluted)	179	185	184	192	192	193
Shares Change (YoY)	-3.03%	0.79%	-4.48%	0.23%	-0.61%	3.37%
EPS (Basic)	0.52	0.50	0.25	0.08	0.23	0.22
EPS (Diluted)	0.52	0.50	0.25	0.08	0.23	0.22
EPS Growth	161.66%	100.00%	212.50%	-65.22%	4.54%	-
Free Cash Flow	163.39	115.22	99.33	163.7	65.26	84.33
Free Cash Flow Per Share	0.92	0.62	0.54	0.85	0.34	0.44
Dividend Per Share	-	0.150	0.100	0.030	0.100	0.100
Dividend Growth	-	50.00%	233.33%	-70.00%	-	25.00%
Gross Margin	82.71%	82.11%	68.47%	51.19%	43.89%	35.91%
Operating Margin	10.10%	10.15%	4.18%	3.73%	5.41%	5.73%
Profit Margin	13.94%	14.55%	7.05%	2.31%	5.15%	5.85%
Free Cash Flow Margin	24.38%	18.11%	15.24%	24.54%	7.62%	11.62%
EBITDA	86.06	83.62	48.96	49.05	69.02	65.24
EBITDA Margin	12.84%	13.14%	7.51%	7.35%	8.06%	8.99%
D&A For EBITDA	18.33	19	21.69	24.14	22.7	23.66
EBIT	67.73	64.62	27.26	24.91	46.32	41.58
EBIT Margin	10.10%	10.15%	4.18%	3.73%	5.41%	5.73%
Effective Tax Rate	20.18%	18.07%	21.39%	33.37%	18.67%	13.08%
Revenue as Reported	670.32	636.27	651.88	667.04	856.73	725.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.